The prevalence of hhv6b-miR-Ro6-2, −3-5p, and miR-U86 in HHV-6A/B IgM or IgG positive and negative patients were not statistically different in OND, neither in MS patients (Figure 2). The gene discussed is CD40LG; the disease is myeloid sarcoma.